Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-19
DOI
10.1038/s41419-022-05408-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 in ferroptosis regulation: the new weapon for the old guardian
- (2022) Yanqing Liu et al. CELL DEATH AND DIFFERENTIATION
- PERK Regulates the Sensitivity of Hepatocellular Carcinoma Cells to High-LET Carbon Ions via either Apoptosis or Ferroptosis
- (2022) Xiaogang Zheng et al. Journal of Cancer
- Should mutant TP53 be targeted for cancer therapy?
- (2022) Zilu Wang et al. CELL DEATH AND DIFFERENTIATION
- Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
- (2022) Yang Yang et al. CELL DEATH AND DIFFERENTIATION
- The p53 network: cellular and systemic DNA damage responses in cancer and aging
- (2022) Pavana Lakshmi Vaddavalli et al. TRENDS IN GENETICS
- Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
- (2022) Shengliang Zhang et al. Biomolecules
- APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
- (2021) Rudy Birsen et al. HAEMATOLOGICA
- Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
- (2021) David A. Sallman et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53
- (2021) Jianyu Wang et al. Cell Death & Disease
- Mutant p53 suppresses innate immune signaling to promote tumorigenesis
- (2021) Monisankar Ghosh et al. CANCER CELL
- Targeting a neoantigen derived from a common TP53 mutation
- (2021) Emily Han-Chung Hsiue et al. SCIENCE
- Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
- (2021) Liz J. Hernández Borrero et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- p53 and Tumor Suppression: It Takes a Network
- (2021) Anthony M. Boutelle et al. TRENDS IN CELL BIOLOGY
- Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c–PCK2 Axis in Basal-Like Breast Cancer
- (2021) Chi-Hong Chao et al. MOLECULAR CANCER RESEARCH
- MicroRNA-324-5p–CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness
- (2021) Dishari Ghatak et al. MOLECULAR CANCER RESEARCH
- iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
- (2021) Delin Chen et al. Nature Communications
- The Function of the Mutant p53-R175H in Cancer
- (2021) Yen-Ting Chiang et al. Cancers
- p53, cancer and the immune response
- (2020) Julianna Blagih et al. JOURNAL OF CELL SCIENCE
- Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
- (2020) Julianna Blagih et al. Cell Reports
- Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
- (2020) Alexandra Garancher et al. NATURE NEUROSCIENCE
- Targeting p53 for the treatment of cancer
- (2020) Michael J. Duffy et al. SEMINARS IN CANCER BIOLOGY
- Gain-of-function mutant p53 in cancer progression and therapy
- (2020) Cen Zhang et al. Journal of Molecular Cell Biology
- The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
- (2020) Zili Zhang et al. Redox Biology
- Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
- (2020) Vitaly Chasov et al. Frontiers in Oncology
- Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site
- (2020) Shuo Chen et al. CANCER CELL
- Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
- (2019) Elena Tirrò et al. Frontiers in Oncology
- Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
- (2019) Winifred Lo et al. Cancer Immunology Research
- The multiple mechanisms that regulate p53 activity and cell fate
- (2019) Antonina Hafner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
- (2019) Min Wang et al. CELL DEATH AND DIFFERENTIATION
- Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
- (2019) Yufei Wang et al. EMBO REPORTS
- Hsp70- and Hsp90-Mediated Regulation of the Conformation of p53 DNA Binding Domain and p53 Cancer Variants
- (2019) Marta Boysen et al. MOLECULAR CELL
- ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
- (2019) Bo Chu et al. NATURE CELL BIOLOGY
- TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
- (2019) Coralie Werbrouck et al. CLINICAL CANCER RESEARCH
- P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
- (2019) Yuechao Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairıng effect in human prostate cancer cell line PC-3
- (2019) Muhammet Burak Batır et al. MOLECULAR BIOLOGY REPORTS
- Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
- (2019) Yaqun Zhang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
- (2019) Marie Chollat-Namy et al. Cell Death & Disease
- Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA
- (2019) Yuan Huang et al. CELL CYCLE
- p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus
- (2019) Daniel Menendez et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1
- (2019) Jin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
- (2019) Lionel Low et al. Nature Communications
- TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
- (2018) Alexander Jethwa et al. BLOOD
- Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1
- (2018) Ling Fang et al. CELL DEATH AND DIFFERENTIATION
- T-cell responses toTP53"hotspot" mutations and unique neoantigens expressed by human ovarian cancers
- (2018) Drew C Deniger et al. CLINICAL CANCER RESEARCH
- CHIP promotes autophagy-mediated degradation of aggregating mutant p53 in hypoxic conditions
- (2018) Meenu Maan et al. FEBS Journal
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- New therapeutic strategies to treat human cancers expressing mutant p53 proteins
- (2018) Giovanni Blandino et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
- (2018) Hilla Solomon et al. ONCOGENE
- Restoring the p53 ‘Guardian’ Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9
- (2018) Sergiu Chira et al. TRENDS IN BIOTECHNOLOGY
- APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
- (2018) Qiang Zhang et al. Cell Death & Disease
- USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
- (2018) Achuth Padmanabhan et al. Nature Communications
- Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
- (2018) Tomer Cooks et al. Nature Communications
- Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells
- (2018) Hengji Zhan et al. ACS Synthetic Biology
- p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
- (2018) Amy Tarangelo et al. Cell Reports
- The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
- (2018) Keerthana Gnanapradeepan et al. Frontiers in Endocrinology
- Tumor suppressive role for kinases phosphorylating p53 in the DNA damage-induced apoptosis
- (2018) Satomi Yogosawa et al. CANCER SCIENCE
- Mutational processes shape the landscape of TP53 mutations in human cancer
- (2018) Andrew O. Giacomelli et al. NATURE GENETICS
- Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases
- (2018) Yun Zhang et al. Nature Communications
- Genomic instability in mutant p53 cancer cells upon entotic engulfment
- (2018) Hannah L. Mackay et al. Nature Communications
- Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication
- (2017) Shilpa Singh et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
- (2017) M Escoll et al. ONCOGENE
- Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
- (2017) Evguenia M Alexandrova et al. Cell Death & Disease
- Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
- (2017) David S. Liu et al. Nature Communications
- The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
- (2017) Yangchun Xie et al. Cell Reports
- RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems
- (2017) Daiha Shin et al. Redox Biology
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
- (2016) M Aggarwal et al. CELL DEATH AND DIFFERENTIATION
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
- (2016) Zhong-Yi Dong et al. CLINICAL CANCER RESEARCH
- COTI-2, a new anticancer drug currently under clinical investigation, targets mutant p53 and negatively modulates the PI3K/AKT/mTOR pathway
- (2016) K.Y. Salim et al. EUROPEAN JOURNAL OF CANCER
- Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer
- (2016) Xing Su et al. HUMAN GENE THERAPY
- Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Reactivation of mutant p53 by capsaicin, the major constituent of peppers
- (2016) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
- (2016) Alejandro Parrales et al. NATURE CELL BIOLOGY
- Activation ofSAT1engages polyamine metabolism with p53-mediated ferroptotic responses
- (2016) Yang Ou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting WEE1 Kinase in Cancer
- (2016) Christopher J. Matheson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?
- (2016) Danielly C.F. Costa et al. Cold Spring Harbor Perspectives in Biology
- Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
- (2016) Perry Tal et al. Oncotarget
- Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging
- (2016) Tongyuan Li et al. Oncotarget
- Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
- (2016) Shang-Jui Wang et al. Cell Reports
- Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53
- (2016) Neil T. Pfister et al. Cold Spring Harbor Perspectives in Medicine
- TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions
- (2016) Nitin H Shirole et al. eLife
- A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
- (2016) Xuetian Yue et al. Cell Discovery
- Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
- (2015) Shengliang Zhang et al. CANCER RESEARCH
- DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53
- (2015) S K Alam et al. CELL DEATH AND DIFFERENTIATION
- Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
- (2015) Masatsugu Hiraki et al. CHEMISTRY & BIOLOGY
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer
- (2015) Aki Miyasaka et al. GYNECOLOGIC ONCOLOGY
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- Amino-terminal p53 mutations lead to expression of apoptosis proficient p47 and prognosticate better survival, but predispose to tumorigenesis
- (2015) Beng Hooi Phang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
- (2015) E K Park et al. Cell Death & Disease
- Targeting Oncogenic Mutant p53 for Cancer Therapy
- (2015) Alejandro Parrales et al. Frontiers in Oncology
- Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression
- (2015) Fabio Valenti et al. Oncotarget
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
- (2014) L. Silwal-Pandit et al. CLINICAL CANCER RESEARCH
- Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
- (2014) Giulio Di Minin et al. MOLECULAR CELL
- Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
- (2014) V Ubertini et al. ONCOGENE
- Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53
- (2013) B. Hong et al. CANCER RESEARCH
- Non-Cell-Autonomous Tumor Suppression by p53
- (2013) Amaia Lujambio et al. CELL
- Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
- (2013) W Hanel et al. CELL DEATH AND DIFFERENTIATION
- Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
- (2013) Maura Sonego et al. EMBO Molecular Medicine
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- Distincttumor protein p53mutants in breast cancer subgroups
- (2012) Anne Dumay et al. INTERNATIONAL JOURNAL OF CANCER
- Mutant p53 protein localized in the cytoplasm inhibits autophagy
- (2011) Eugenia Morselli et al. CELL CYCLE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
- (2011) C. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs
- (2010) Silvia Di Agostino et al. CELL CYCLE
- INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
- (2010) Alberto A Chiappori et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model
- (2010) Jill E. Kucab et al. FEBS Journal
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
- (2010) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- Mutational spectra of human cancer
- (2009) Gerd P. Pfeifer et al. HUMAN GENETICS
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A common gain of function of p53 cancer mutants in inducing genetic instability
- (2009) D P Liu et al. ONCOGENE
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity
- (2008) Sonja Wolff et al. CELL RESEARCH
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
- (2008) J. E. Kravchenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started